Paracetamol in preterm babies: does it boost brain development?

NCT ID NCT06064825

Recruiting now Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Apr 20, 2026 · Last updated Jun 13, 2026 · Updated 10 times

Summary

This study follows up on 500 extremely preterm infants who were part of a larger trial testing paracetamol to close a common heart vessel. Researchers want to see if those who received paracetamol have better thinking and learning skills at age 2. Parents will answer an online questionnaire about their child's abilities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU d'Angers
RECRUITING

Angers, France

Contact
CHU de Montpellier
RECRUITING

Montpellier, France

Contact
CHU de Nantes
RECRUITING

Nantes, France

Contact
CHU de Strasbourg
RECRUITING

Strasbourg, France

Contact
CHU de Tours
RECRUITING

Tours, France

Contact
Cochin - APHP
RECRUITING

Paris, France

Contact
Hopital Robert Debré
RECRUITING

Paris, France

Contact
Hôpital Femme Mère Enfant
RECRUITING

Bron, France

Contact

Conditions

Explore the condition pages connected to this study.

PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY